Showing 1 - 13 results of 13 for search '"Influenza virus A"', query time: 0.07s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Immunobiological properties of inactivated anti-highly pathogenic avian influenza vaccines based on antigens of А/Н5N1 avian influenza virus strains of different virulence by S. V. Frolov, I. A. Chvala, N. V. Moroz, V. Yu. Kulakov, V. Yu. Sosipatorova, D. B. Andreychuk

    Published 2022-12-01
    “…The inoculation dose of H5N1 highly pathogenic avian influenza virus А/chicken/Primorsky/85/08 strain antigen for protection from H5N8 highly pathogenic avian influenza virus A/duck/KChR/1590-20/20 strain shall be at least 294 HAU. …”
    Get full text
    Article
  5. 5

    H3N2 Virus as Causative Agent of ARDS Requiring Extracorporeal Membrane Oxygenation Support by Adriano Peris, Giovanni Zagli, Pasquale Bernardo, Massimo Bonacchi, Morena Cozzolino, Lucia Perretta, Alberta Azzi, Giovanni Cianchi

    Published 2014-01-01
    “…Pandemic influenza virus A(H1N1) 2009 was associated with a higher risk of viral pneumonia in comparison with seasonal influenza viruses. …”
    Get full text
    Article
  6. 6

    Paper‐Based RNase Digestion toward Viral Nucleic Acid Self‐Tests by Georgios Chondrogiannis, Anna Toldrà, Martin Hanze, Mahiar Max Hamedi

    Published 2025-01-01
    “…The potential of this method to protect RNA from digestion is further demonstrated, by pretreating diluted saliva samples spiked with Influenza Virus A (IVA) genomic RNA, which allows its amplification and colorimetric detection by lateral flow strips. …”
    Get full text
    Article
  7. 7

    Hand hygiene for prevention and control of viral infections: the role of Amuchina Gel Xgerm [Accepted for publication] by Claudio Cermelli, Elisabetta Blasi, Alessandra Capezzone de Joannon, Maria Ilaria Roselli, Daniele Frollano, Michela Procaccini

    Published 2024-12-01
    “…For adenovirus type 5, human coxsakievirus, herpesvirus 1 and influenza virus A H1N1, a ≥4 log10 reduction of virus titer was obtained already after 30 s. …”
    Get full text
    Article
  8. 8

    A Novel Lactococcal Vaccine Expressing a Peptide from the M2 Antigen of H5N2 Highly Pathogenic Avian Influenza A Virus Prolongs Survival of Vaccinated Chickens by Kaleb A. Reese, Christopher Lupfer, Rudd C. Johnson, Georgi M. Mitev, Valerie M. Mullen, Bruce L. Geller, Manoj Pastey

    Published 2013-01-01
    “…Vaccinated and nonvaccinated birds were challenged with high pathogenic avian influenza virus A subtype H5N2. Birds vaccinated with LL-M2e or KLH-M2e had median survival times of 5.5 and 6.0 days, respectively, which were significantly longer than non-vaccinated birds (3.5 days). …”
    Get full text
    Article
  9. 9

    Analysis of marker substitutions in A/chicken/Astrakhan/2171-1/2020 H5N8 isolate of avian influenza virus recovered in the Astrakhan Oblast by N. G. Zinyakov, A. V. Andriyasov, Ye. V. Ovchinnikova, A. A. Kozlov, P. D. Zhestkov, D. B. Andreychuk, I. A. Chvala

    Published 2021-07-01
    “…Data on detection of the marker substitutions in viral proteins of avian influenza virus A/chicken/Astrakhan/2171-1/2020 isolate are presented in the paper. …”
    Get full text
    Article
  10. 10

    Selective suppression of influenza A/H5N1 virus replication <i>in vitro</i> using nanocomplexes consisting of siRNA and aminopropylsilanol nanoparticles by Marina N. Repkova, Asya S. Levina, Oleg Yu. Mazurkov, Elena V. Makarevich, Ekaterina I. Filippova, Natalya A. Mazurkova, Valentina F. Zarytova

    Published 2024-12-01
    “…Materials and methods. MDCK cells, influenza virus A/chicken/Kurgan/05/2005 (A/H5N1), aminopropylsilanol nanoparticles, and native and modified siRNA molecules. …”
    Get full text
    Article
  11. 11

    Changes in infant respiratory pathogens pre-, during, and post-COVID-19 non-pharmacological interventions in Beijing by Tongying Han, Yajuan Wang, Di Zhang, Ying Li, Li Zhang, Jin Yan, Chi Li, Shengnan Yang, Litao Guo, Huijuan Yan

    Published 2025-01-01
    “…The specimens were tested for 14 respiratory pathogens, including influenza virus A (Flu A), influenza virus B, respiratory syncytial virus, parainfluenza virus (PIV), adenovirus (ADV), human metapneumovirus (HMPV), human bocavirus, human rhinovirus (HRV), coronavirus, Chlamydia trachomatis, Chlamydia pneumoniae (C.pn), Mycoplasma pneumoniae, Bordetella pertussis, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …”
    Get full text
    Article
  12. 12

    A new pathogen pattern of acute respiratory tract infections in primary care after COVID-19 pandemic: a multi-center study in southern China by Heng Zhang, Deqi Meng, Hao Huang, Longhao Feng, Yushao Li, Yong Jiang, Ling Wang, Ruoyu Deng, Yuchun Sun, Binqin Chen, Fuzhao Liao, Yumei Wu, Huancai Zheng, Junling Ding, Maokun Chen, Cui Zeng, Wanting Zhao, Meng Hou, Yinyan Li, Zhishen Li, Haibo Xia, Kai Yang, Lingwei Wang

    Published 2025-01-01
    “…Influenza virus B (18.2%), influenza virus A (16.8%) and severe acute respiratory syndrome coronavirus 2 (14.1%) were the three leading viral pathogens, and H. influenzae (36.1%), S. anginosus (15.7%) and S. pneumoniae (8.4%) were the three leading bacterial pathogens. …”
    Get full text
    Article
  13. 13

    Genetic characteristics of influenza A and B viruses circulating in Russia in 2019–2023 by Svetlana B. Yatsyshina, Anna A. Artamonova, Maria A. Elkina, Anna V. Valdokhina, Victoria P. Bulanenko, Aleksandra A. Berseneva, Vasily G. Akimkin

    Published 2024-12-01
    “…Sequencing data revealed a mutation of adamantane resistance S31N in M2 in all studied influenza viruses A(H1N1)pdm09 and A(H3N2). Conclusions. …”
    Get full text
    Article